4D Molecular Therapeutics Says US FDA Clears Its IND Application for Potential Geographic Atrophy Treatment
4D Molecular Therapeutics Says US FDA Clears Its IND Application for Potential Geographic Atrophy Treatment
4d分子治疗公司表示，美国FDA已经批准其针对潜在地理性萎缩的治疗工业化学工业化工业化工工艺的IND申请。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册